244 related articles for article (PubMed ID: 11711031)
21. Urocortin is the principal ligand for the corticotrophin-releasing factor binding protein in the ovine brain with no evidence for a sauvagine-like peptide.
Baigent SM; Lowry PJ
J Mol Endocrinol; 2000 Feb; 24(1):53-63. PubMed ID: 10656997
[TBL] [Abstract][Full Text] [Related]
22. D-amino acid-substituted analogs of corticotropin-releasing hormone (CRH) and urocortin with selective agonist activity at CRH1 and CRH2beta receptors.
Wei ET; Thomas HA; Christian HC; Buckingham JC; Kishimoto T
Peptides; 1998; 19(7):1183-90. PubMed ID: 9786168
[TBL] [Abstract][Full Text] [Related]
23. Human CRF2 alpha and beta splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay.
Ardati A; Goetschy V; Gottowick J; Henriot S; Valdenaire O; Deuschle U; Kilpatrick GJ
Neuropharmacology; 1999 Mar; 38(3):441-8. PubMed ID: 10219982
[TBL] [Abstract][Full Text] [Related]
24. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30.
Rühmann A; Bonk I; Lin CR; Rosenfeld MG; Spiess J
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15264-9. PubMed ID: 9860957
[TBL] [Abstract][Full Text] [Related]
25. Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site.
Dautzenberg FM; Wille S; Lohmann R; Spiess J
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):4941-6. PubMed ID: 9560207
[TBL] [Abstract][Full Text] [Related]
26. A variant of the human corticotropin-releasing factor (CRF) receptor: cloning, expression and pharmacology.
Ross PC; Kostas CM; Ramabhadran TV
Biochem Biophys Res Commun; 1994 Dec; 205(3):1836-42. PubMed ID: 7811272
[TBL] [Abstract][Full Text] [Related]
27. Corticotropin-releasing factor-like peptides increase cytosolic [Ca2+] in human epidermoid A-431 cells.
Kiang JG
Eur J Pharmacol; 1997 Jun; 329(2-3):237-44. PubMed ID: 9226418
[TBL] [Abstract][Full Text] [Related]
28. Five amino acids of the Xenopus laevis CRF (corticotropin-releasing factor) type 2 receptor mediate differential binding of CRF ligands in comparison with its human counterpart.
Dautzenberg FM; Higelin J; Brauns O; Butscha B; Hauger RL
Mol Pharmacol; 2002 May; 61(5):1132-9. PubMed ID: 11961131
[TBL] [Abstract][Full Text] [Related]
29. Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor.
Kostich WA; Chen A; Sperle K; Largent BL
Mol Endocrinol; 1998 Aug; 12(8):1077-85. PubMed ID: 9717834
[TBL] [Abstract][Full Text] [Related]
30. Molecular cloning and functional expression of the mouse CRF2(a) receptor splice variant.
Dautzenberg FM; Higelin J; Wille S; Brauns O
Regul Pept; 2004 Sep; 121(1-3):89-97. PubMed ID: 15256278
[TBL] [Abstract][Full Text] [Related]
31. The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: generation of chimeric receptors with a novel ligand-selective profile.
Dautzenberg FM; Kilpatrick GJ; Wille S; Hauger RL
J Neurochem; 1999 Aug; 73(2):821-9. PubMed ID: 10428081
[TBL] [Abstract][Full Text] [Related]
32. Characterisation using microphysiometry of CRF receptor pharmacology.
Smart D; Coppell A; Rossant C; Hall M; McKnight AT
Eur J Pharmacol; 1999 Aug; 379(2-3):229-35. PubMed ID: 10497910
[TBL] [Abstract][Full Text] [Related]
33. N-glycosylation of CRF receptor type 1 is important for its ligand-specific interaction.
Assil IQ; Abou-Samra AB
Am J Physiol Endocrinol Metab; 2001 Nov; 281(5):E1015-21. PubMed ID: 11595658
[TBL] [Abstract][Full Text] [Related]
34. Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding.
Wille S; Sydow S; Palchaudhuri MR; Spiess J; Dautzenberg FM
J Neurochem; 1999 Jan; 72(1):388-95. PubMed ID: 9886092
[TBL] [Abstract][Full Text] [Related]
35. Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: evidence for evolutionary differences.
Dautzenberg FM; Py-Lang G; Higelin J; Fischer C; Wright MB; Huber G
J Pharmacol Exp Ther; 2001 Jan; 296(1):113-20. PubMed ID: 11123370
[TBL] [Abstract][Full Text] [Related]
36. Corticotropin-releasing hormone receptor expression and functional coupling in neonatal cardiac myocytes and AT-1 cells.
Heldwein KA; Redick DL; Rittenberg MB; Claycomb WC; Stenzel-Poore MP
Endocrinology; 1996 Sep; 137(9):3631-9. PubMed ID: 8756527
[TBL] [Abstract][Full Text] [Related]
37. Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors.
Vita N; Laurent P; Lefort S; Chalon P; Lelias JM; Kaghad M; Le Fur G; Caput D; Ferrara P
FEBS Lett; 1993 Nov; 335(1):1-5. PubMed ID: 8243652
[TBL] [Abstract][Full Text] [Related]
38. Functional, endogenously expressed corticotropin-releasing factor receptor type 1 (CRF1) and CRF1 receptor mRNA expression in human neuroblastoma SH-SY5Y cells.
Schoeffter P; Feuerbach D; Bobirnac I; Gazi L; Longato R
Fundam Clin Pharmacol; 1999; 13(4):484-9. PubMed ID: 10456290
[TBL] [Abstract][Full Text] [Related]
39. Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor.
Perrin MH; Donaldson CJ; Chen R; Lewis KA; Vale WW
Endocrinology; 1993 Dec; 133(6):3058-61. PubMed ID: 8243338
[TBL] [Abstract][Full Text] [Related]
40. Signaling properties of mouse and human corticotropin-releasing factor (CRF) receptors: decreased coupling efficiency of human type II CRF receptor.
Xiong Y; Xie LY; Abou-Samra AB
Endocrinology; 1995 May; 136(5):1828-34. PubMed ID: 7720627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
